Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Effectiveness of psychologically focused group interventions for Multiple Sclerosis: A review of the experimental literature.
CLINICAL PROBLEM-SOLVING. A Breakthrough Diagnosis.
Oligodendrocytes in a Nutshell.
Hypomyelinating disorders: An MRI approach.
Fatigue in childhood multiple sclerosis.
Genetically Modified Pig Models for Neurodegenerative Disorders.
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.
Participation as an Outcome in Multiple Sclerosis Falls-Prevention Research: Consensus Recommendation from the International MS Falls Prevention Research Network.
Defective structural RNA processing in relapsing-remitting multiple sclerosis.
Multiple sclerosis: Severity of cognitive deficits in MS linked to disease course.
Alemtuzumab in multiple sclerosis: an update.
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.
Cause and prevention of demyelination in a model multiple sclerosis lesion.
Teriflunomide - a new oral agent for multiple sclerosis treatment.
Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
A Model of Population and Subject (MOPS) Intensities with Application to Multiple Sclerosis Lesion Segmentation.
Physical rehabilitation interventions in nonambulatory people with multiple sclerosis: a systematic review.
On the Structure and functions of gelatinase B/Matrix metalloproteinase-9 in neuroinflammation.
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Control of Macrophage Dynamics as A Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation.
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.
Evaluation of Muscle Performance and Cardiopulmonary Fitness in Patients with Multiple SclerosisImplications for Rehabilitation.
Local dynamic stability as a responsive index for the evaluation of rehabilitation effect on fall risk in patients with multiple sclerosis: a longitudinal study.
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity.
Pages
« first
‹ previous
…
488
489
490
491
492
493
494
495
496
…
next ›
last »